Investigating a protein's role in enhancing opioid pain relief and reducing tolerance
G alpha Z subunit as a potential therapeutic target to modulate mu opioid receptor pharmacology
This study is looking at how a specific protein called Gαz affects how well opioid medications work for pain relief, with the goal of finding better ways to help people manage pain without building up a tolerance to the drugs.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-10580415 on NIH RePORTER |
What this research studies
This research focuses on understanding how the Gαz protein influences the effectiveness of opioid medications. By examining the interactions between Gαz and opioid receptors, the study aims to identify ways to improve pain relief while minimizing the development of tolerance to these medications. The researchers will use advanced cellular techniques to explore how different combinations of G protein subunits affect opioid pharmacology. This could lead to new therapeutic strategies for managing pain more effectively.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who experience chronic pain and are currently using or considering opioid medications.
Not a fit: Patients who do not use opioids or have conditions unrelated to opioid pharmacology may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved opioid treatments that provide better pain relief with a lower risk of tolerance.
How similar studies have performed: Previous studies have shown promising results in enhancing opioid efficacy through similar mechanisms, suggesting potential for success in this approach.
Where this research is happening
Rochester, United States
- University of Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Bidlack, Jean M — University of Rochester
- Study coordinator: Bidlack, Jean M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.